Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc | Director | Common Stock | 122K | $107K | $0.88 | Jun 10, 2024 | Direct |
Mereo BioPharma Group plc | Director | American Depositary Shares representing Ordinary Shares | 25.1K | $99.9K | $3.99 | Jun 17, 2024 | Direct |
Mereo BioPharma Group plc | Director | Share Options (Right to buy) | 45K | $45.5K | $1.01 | Feb 8, 2024 | Direct |
Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 23, 2023 | Direct | ||
Mereo BioPharma Group plc | Director | Deferred Restricted Stock Units | 30.8K | Feb 8, 2024 | Direct | ||
LogicBio Therapeutics, Inc. | Director | Common Stock | 0 | $2.01 | Nov 16, 2022 | Direct | |
LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct |